Pointing to a wide spectrum of visfatin and vaspin activities the aim of the study was to measure the serum levels of visfatin and vaspin in HCC patients with subsequent differentiation with respect to disease etiology and the severity of liver dysfunction. The gene discussed is NAMPT; the disease is hepatocellular carcinoma.